Emily Titus

Senior Vice President, Technical Operations • Notch Therapeutics

Emily obtained her PhD from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, where she used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions. At Notch, she oversees the Technical Operations function, which includes Process and Analytical Development, Manufacturing Sciences, Engineering and Project Management. Previously, she held the position of Vice President, Technology Advancement at CCRM, where she built cell reprogramming, genome engineering and pluripotent stem cell differentiation programs and led the company incubation program that culminated in the launch of Notch Therapeutics.


Also Speaking

Michael Von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen

Luca Alberici

General Manager, Milan Facility • AGC Biologics

Emily Chee

General Manager, Americas • Novartis

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.